Kekkan Biologics
Develops antibody biologics for cancer and fibrotic disorders, initially targeting triple-negative breast cancer
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Kekkan Biologics
Kekkan Biologics develops antibody therapeutics using a proprietary target-selection and antibody-development platform. Its lead program, Lyvepodimab, is a bispecific antibody targeting PD1 and LVRF.
The company is advancing Lyvepodimab toward clinical development, initially for triple-negative breast cancer, with potential applications in metastatic cancers and fibrotic disorders. Kekkan is a spin-off from research institutions in Nice and is incubated by Quest for Health in Strasbourg, France.
Product: A proprietary biologics platform and antibody therapeutics, including the bispecific antibody Lyvepodimab targeting PD1 and LVRF.
Jobs at Kekkan Biologics
More biotech & pharma companies
Keybio
Microbiological testing and regulatory support for industrial product developers and manufacturersNew on EvolcKimialys
Biosensing surface chemistry and lateral flow assay development for diagnostics and drug discovery labsNew on EvolcKreatis
In silico toxicology and ecotoxicology predictions for chemical regulatory dossiers, used in place of animal testingNew on EvolcLaboratoires Delbert
Preserves and markets essential medicines for patients and healthcare professionals, with a focus on critical and rare-disease needsNew on EvolcLaboratoires Kol
Makes treatments available to patients with rare diseases and unmet needs, with a focus on ophthalmology and pediatricsNew on EvolcLaboratoires Majorelle
Pharmaceutical treatments, medical devices and family health products for patients and healthcare professionalsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.